Press Release


For more information:
Rebecca Stauffer
AAPS Communications Manager
[email protected]

Anurag Rathore, Ph.D., to Become Editor-in-Chief of The AAPS Journal
Current Editor-in-Chief Ho-Leung Fung, Ph.D., FAAPS, to Retire at End of 2023

Arlington, VA—AAPS is pleased to announce Anurag Rathore, Ph.D., will become Editor-in-Chief of The AAPS Journal in 2024, following the retirement of the current Editor-in-Chief Ho-Leung Fung, Ph.D., FAAPS, who has led the peer-reviewed publication for 18 years.

“Over the past two decades as an Associate Editor and then Editor-in-Chief, I have been privileged to interact with, and learn from, outstanding scientists who authored and reviewed manuscripts for The AAPS Journal. I believe that our editorial team has moved the journal forward to being a well-regarded scientific publication in our community,” Dr. Fung said. “The AAPS Journal can look forward to further progress under the leadership of Professor Anurag Rathore, who has an outstanding research record in the pharmaceutical industry and academia. I have every confidence that The AAPS Journal will continue to publish novel and significant findings that will move our field forward.”

“Professor Fung has done an amazing job of establishing The AAPS Journal as the credible journal of choice for the pharmaceutical scientific community,” Dr. Rathore said. “I aim to carry his legacy forward and together with AAPS stakeholders make the journal an outlet that reports on innovation, best practices, and policies on topics that are of current interest to researchers in pharmaceutical sciences.”

“Dr. Rathore brings with him significant expertise in process analytical technology in biotherapeutic products,” 2024 AAPS President Gopi Shankar, Ph.D., M.B.A., FAAPS, said. “I’m looking forward to the direction he sets for The AAPS Journal.”

Dr. Rathore is an Institute Chair Professor at the Department of Chemical Engineering, Indian Institute of Technology Delhi, in Delhi, India. Previously, he worked in management positions at Amgen and Pharmacia Corp. He has published extensively on topics related to the development of biotherapeutic products, authoring more than 700 publications and presentations. Six of his papers have been published in The AAPS Journal.

His previous editorial roles include Editor-in-Chief of Preparative Biochemistry and Biotechnology, Associate Editor for the Journal of Chemical Technology and Biotechnology, and the PDA Journal of Pharmaceutical Science and Technology, among others. He also recently served as guest editor for The AAPS Journal special issue on process analytical technology.

For the past three years he has served as Chair of the AAPS Process Analytical Technology Community.

The AAPS Journal can be accessed at www.springer.com/journal/12248.


American Association of Pharmaceutical Scientists (AAPS) is a 501(c)(3) non-profit association of more than 7,000 scientists and professionals employed in academia, industry, regulatory, and other research related to the pharmaceutical sciences worldwide. Its mission is to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health, which members pursue through four peer-reviewed journals and various events in person and online. www.aaps.org

AAPS journals publish articles covering the breadth of pharmaceutical science, including complementary disciplines like chemistry, biology, and engineering. AAPS publishes four peer-reviewed journals: The AAPS Journal, AAPS PharmSciTech, Pharmaceutical Research, and AAPS Open. The latter is AAPS’ first fully open access journal. It is freely available worldwide, and authors retain copyright. All four journals are available with AAPS membership or through institutional access. www.aaps.org/journals